Insights

Targeted Cancer Therapies BAKX Therapeutics specializes in developing targeted cancer therapies through a unique approach focused on the mitochondrial apoptosis pathway. This specialized focus allows for tailored solutions in the oncology sector, presenting an opportunity for partnership or collaboration with hospitals and cancer treatment centers.

Orally Active Therapeutics With a focus on creating orally active therapeutics that can be used alone or in combination with existing oncology treatments, BAKX Therapeutics offers a promising solution for healthcare providers seeking innovative cancer treatment options. This unique product offering could be a compelling sales opportunity for pharmaceutical distributors or medical institutions.

Integrated & Iterative Platform The company's integrated and iterative platform, combining knowledge, experimentation, and simulation, provides a cutting-edge approach to drug development. This advanced technology stack could be of interest to research organizations, universities, or pharmaceutical companies looking to enhance their drug discovery process through collaboration or licensing agreements.

Strategic Funding With a recent funding of $25M, BAKX Therapeutics demonstrates financial stability and growth potential. This strong financial backing could signal readiness for partnerships, investments, or expansion opportunities, making it an attractive target for investors or companies looking to align with a well-funded biotechnology firm.

Distinct Competitive Positioning In comparison to similar companies in the biotechnology research industry, BAKX Therapeutics stands out for its focus on regulated apoptosis and structure-based drug design. This unique positioning could be leveraged as a competitive advantage in sales pitches or marketing strategies to differentiate the company's offerings and attract potential clients.

BAKX Therapeutics Tech Stack

BAKX Therapeutics uses 8 technology products and services including Google Analytics, Google Font API, Font Awesome, and more. Explore BAKX Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Revslider
    Miscellaneous
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Twenty Twenty-One
    Web Platform Extensions

Media & News

BAKX Therapeutics's Email Address Formats

BAKX Therapeutics uses at least 1 format(s):
BAKX Therapeutics Email FormatsExamplePercentage
FLast@bakxtx.comJDoe@bakxtx.com
50%
FLast@bakxtx.comJDoe@bakxtx.com
50%

Frequently Asked Questions

Where is BAKX Therapeutics's headquarters located?

Minus sign iconPlus sign icon
BAKX Therapeutics's main headquarters is located at New York | Boston, US. The company has employees across 1 continents, including North America.

What is BAKX Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
BAKX Therapeutics's official website is bakxtx.com and has social profiles on LinkedIn.

What is BAKX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
BAKX Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BAKX Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, BAKX Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Head Of Protein Sciences/Biochemistry/Biophysics: N. G.Founder & Chief Executive Officer: S. K.Director Of Finance And Operations: J. M.. Explore BAKX Therapeutics's employee directory with LeadIQ.

What industry does BAKX Therapeutics belong to?

Minus sign iconPlus sign icon
BAKX Therapeutics operates in the Biotechnology Research industry.

What technology does BAKX Therapeutics use?

Minus sign iconPlus sign icon
BAKX Therapeutics's tech stack includes Google AnalyticsGoogle Font APIFont AwesomejQueryRevsliderYoast SEOX-XSS-ProtectionTwenty Twenty-One.

What is BAKX Therapeutics's email format?

Minus sign iconPlus sign icon
BAKX Therapeutics's email format typically follows the pattern of . Find more BAKX Therapeutics email formats with LeadIQ.

How much funding has BAKX Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, BAKX Therapeutics has raised $25M in funding. The last funding round occurred on Nov 18, 2021 for $25M.

When was BAKX Therapeutics founded?

Minus sign iconPlus sign icon
BAKX Therapeutics was founded in 2020.
BAKX Therapeutics

BAKX Therapeutics

Biotechnology Research New York | Boston, United States11-50 Employees

We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations  

We have built an integrated & iterative platform based on knowledge, experimentation, and simulation that allows us to better interrogate and harness the power of regulated apoptosis

We are developing a suite of orally active therapeutics which can act as single agents or in combination with other oncology therapies to create better and lasting outcomes for cancer patients

Section iconCompany Overview

Headquarters
New York | Boston, US
Website
bakxtx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    BAKX Therapeutics has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $25M.

Section iconFunding & Financials

  • $25M

    BAKX Therapeutics has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $25M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.